by Richard Daverman, PhD
September 18, 2013 -- Zhejiang Huahai Pharma received CFDA approval to produce efavirenz, an oral non-nucleoside reverse transcriptase inhibitor (NNRTI) used to control the symptoms of AIDS. Huahai is the first China drugmaker approved to make the drug. Huahai produced efavirenz API for Merck, which marketed the drug under the name Stocrin. More details....
Stock Symbols: (SHA: 600521) (NYSE: MRK)
Help employers find you! Check out all the jobs and post your resume.
